Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 610

1.

Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):799-804. doi: 10.1158/1055-9965.EPI-07-2620. Epub 2008 Apr 1.

2.

Data sources for measuring colorectal endoscopy use among Medicare enrollees.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2118-27.

3.

Validation of self-reported history of colorectal cancer screening.

Khoja S, McGregor SE, Hilsden RJ.

Can Fam Physician. 2007 Jul;53(7):1192-7.

4.

Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?

Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM.

Med Care. 2008 Sep;46(9 Suppl 1):S84-90. doi: 10.1097/MLR.0b013e31817fdf80.

PMID:
18725838
5.

Trends in colorectal cancer testing among Medicare subpopulations.

Fenton JJ, Cai Y, Green P, Beckett LA, Franks P, Baldwin LM.

Am J Prev Med. 2008 Sep;35(3):194-202. doi: 10.1016/j.amepre.2008.05.029. Epub 2008 Jul 10.

PMID:
18619761
6.

Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.

Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, Halek K, Griffin JM, van Ryn M, Fisher DA.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):768-76. doi: 10.1158/1055-9965.EPI-07-0759. Epub 2008 Apr 1.

7.

Trends in colorectal cancer test use in the medicare population, 1998-2005.

Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML.

Am J Prev Med. 2009 Jul;37(1):1-7. doi: 10.1016/j.amepre.2009.03.009. Epub 2009 May 7.

PMID:
19423273
8.

Testing for prostate and colorectal cancer: comparison of self-report and medical record audit.

Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Hughes Sinclair A, Madlon-Kay DJ, Nadel M.

Prev Med. 2004 Jul;39(1):27-35.

PMID:
15207983
9.

Accuracy of self-reports of fecal occult blood tests and test results among individuals in the carpentry trade.

Lipkus IM, Samsa GP, Dement J, Skinner CS, Green LS, Pompeii L, Ransohoff DF.

Prev Med. 2003 Nov;37(5):513-9.

PMID:
14572436
10.

Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases.

Bastani R, Glenn BA, Maxwell AE, Ganz PA, Mojica CM, Chang LC.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):791-8. doi: 10.1158/1055-9965.EPI-07-2625. Epub 2008 Apr 1.

11.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

PMID:
15150305
12.

Diagnostic testing following fecal occult blood screening in the elderly.

Lurie JD, Welch HG.

J Natl Cancer Inst. 1999 Oct 6;91(19):1641-6.

PMID:
10511591
13.

Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?

Vernon SW, Tiro JA, Vojvodic RW, Coan S, Diamond PM, Greisinger A, Fernandez ME.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):758-67. doi: 10.1158/1055-9965.EPI-07-2855. Epub 2008 Apr 1.

14.

Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?

Koroukian SM, Litaker D, Dor A, Cooper GS.

Med Care. 2005 May;43(5):445-52.

PMID:
15838408
15.

Fecal occult blood test use by Kansas medicare beneficiaries.

Engelman KK, Ellerbeck EF, Ahluwalia JS, Nazir N, Velasco A.

Prev Med. 2001 Dec;33(6):622-6.

PMID:
11716659
16.

Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in medicare enrollees.

Fenton JJ, Tancredi DJ, Green P, Franks P, Baldwin LM.

J Am Geriatr Soc. 2009 Mar;57(3):412-8. doi: 10.1111/j.1532-5415.2008.02143.x. Epub 2009 Jan 16.

PMID:
19175435
17.

Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures.

Katz JN, Barrett J, Liang MH, Bacon AM, Kaplan H, Kieval RI, Lindsey SM, Roberts WN, Sheff DM, Spencer RT, Weaver AL, Baron JA.

Arthritis Rheum. 1997 Sep;40(9):1594-600.

PMID:
9324013
18.

Racial differences in colorectal cancer test use by Medicare consumers.

Schenck AP, Klabunde CN, Davis WW.

Am J Prev Med. 2006 Apr;30(4):320-6.

PMID:
16530619
19.

Barriers to colorectal cancer screening among Medicare consumers.

Klabunde CN, Schenck AP, Davis WW.

Am J Prev Med. 2006 Apr;30(4):313-9.

PMID:
16530618
20.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475

Supplemental Content

Support Center